Tag: liver cancer

abstract of the year

Authors receive accolade of ‘Abstract of the Year’ at SIR 2022

At the Society of Interventional Radiology (SIR) 2022 Annual Meeting (11-16 June, Boston, USA), four of the abstracts submitted were declared ‘Abstract of the...
trisalus

TriSalus presents preclinical data on proprietary infusion technology at SIR 2022

TriSalus’ clinical leadership team presented new preclinical data at the Society of Interventional Radiology (SIR) 2022 Annual Scientific Meeting (11–16 June, Boston, USA). The...
holmium-166

Holmium-166 SIRT demonstrates safety and efficacy in the treatment of HCC

University Medical Center Utrecht (Utrecht, Netherlands) recently published the latest results from the HEPAR Primary study, which evaluated the safety and efficacy of Holmium-166...
RCTs

Phase III RCTs needed to prove radiofrequency ablation is effective against...

Interventional radiologists must become involved in the multidisciplinary development of phase III randomised controlled trials (RCTs) to further assess the role of radiofrequency ablation...
Interventional News for specialists

Targeted immunotherapy treatment shows promise for treating for advanced liver cancer

Advanced stage liver tumours may be safely treated through image-guided injections of an immunotherapy approved for melanoma, according to phase 1 data presented at...

Surefire Medical appoints Mary T Szela CEO and president

Szela brings nearly 30 years of progressive leadership experience to Surefire building global billion-dollar brands, advancing pipeline products in the biotechnology, medical products, and...

Vast majority of patients prefer radial access for embolization therapies in...

“While both radial and femoral accesses are safe and effective for transarterial liver embolization, it is clear that the patients prefer radial access,” said Marcelo Guimaraes, Charleston, USA, who was presenting on the...